The following areas are of research interest for the Hepatitis C Virus (HCV):
While the research interests listed within the therapeutic areas are of focus to BIPI, other novel research interests may be considered.
A brief synopsis must be submitted to BIPI for consideration of interest.
The following items are required for submission of the synopsis:
Once/If BIPI confirms interest in the synopsis, additional details in the form of a full proposal must be submitted. The following information will be required in the proposal:
Submission of a preliminary Proposal does not imply or guarantee approval. All proposals will be reviewed based on scientific merit and available funding.
Please click on the link below to access BI’s online submission site.
Investigators outside of the United States interested in Virology IIS are encouraged to visit http://www.boehringer-ingelheim.com/clinical_trials/iis_virology.html.
To contact Boehringer Ingelheim Pharmaceuticals, Inc., Medical IIS Office, please call 877-757-7354.